Clinical Trial Update: Blockade of Vascular Potassium Channels During Human Endotoxemia [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated blockade of vascular potassium channels in humans with endotoxemia, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endotoxemia

Snippet

Sponsor: Radboud University Medical Center | Conditions: Endotoxemia | Phase 1 | Status: COMPLETED